• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振平扫可能提高隐匿性系统性硬化症无症状患者心脏受累的检出率和预测预后。

Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis.

机构信息

Department of Diagnostic Imaging, Area of Cardiovascular and Interventional Imaging, Abruzzo Health Unit 1, Via Saragat -località Campo di Pile, 67100, L'Aquila, Italy.

SIRM Foundation, Italian Society of Medical and Interventional Radiology (SIRM), 20122, Milan, Italy.

出版信息

Sci Rep. 2022 Mar 24;12(1):5125. doi: 10.1038/s41598-022-09064-5.

DOI:10.1038/s41598-022-09064-5
PMID:35332224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8948177/
Abstract

Systemic sclerosis (SSc) is an uncommon autoimmune disease. Aim of the study was to detect the occult cardiac involvement in asymptomatic SSc patients of recent onset (indicative of a more aggressive disease) with unenhanced Cardiac Magnetic Resonance (CMR). Our historical prospective study included naïve SSc patients of recent onset. Modified Rodnan Skin Score (mRSS) and Scleroderma Clinical Trial Consortium Damage Index (SCTC-DI) were calculated. Cardiac volumes and global myocardial strain were assessed and also compared with healthy group values. Pericardial involvement was further recorded. Thirty-one patients met inclusion criteria (54 ± 12 years; 1 M). Mean duration of disease was 6.8 years. All patients showed preserved systolic function. Higher incidence of pericardial involvement was founded in patients with disease accrual damage (OR: 9.6, p-value 0.01). Radial and longitudinal strain values resulted significantly different between healthy and SSc patients. GRS and GLS showed an independent predictive validity on damage accrual (HR: 1.22 and 1.47, respectively). Best C-index for disease progression was reached when strain values and pericardial evaluation were added to conventional risk factors (0.97, p-value: 0.0001). Strain analysis by CMR-TT may show a high capability both in identifying early cardiac involvement and stratifying its clinical aggressiveness, regardless of the standard damage indices and CMR contrast-dependent biomarker.

摘要

系统性硬化症(SSc)是一种罕见的自身免疫性疾病。本研究旨在检测近期发病(提示疾病更具侵袭性)的无症状 SSc 患者隐匿性心脏受累,这些患者未经增强型心脏磁共振(CMR)检查。我们的历史前瞻性研究纳入了近期发病的未经治疗的 SSc 患者。计算改良 Rodnan 皮肤评分(mRSS)和硬皮病临床试验联盟损害指数(SCTC-DI)。评估心脏容积和整体心肌应变,并与健康组进行比较。进一步记录心包受累情况。31 名患者符合纳入标准(54±12 岁;1 名男性)。疾病的平均病程为 6.8 年。所有患者均表现出保留的收缩功能。在疾病进展导致损害的患者中,心包受累的发生率更高(OR:9.6,p 值为 0.01)。健康患者和 SSc 患者之间的径向和纵向应变值存在显著差异。GRS 和 GLS 对损害进展具有独立的预测价值(HR:分别为 1.22 和 1.47)。当将应变值和心包评估添加到常规危险因素中时,疾病进展的最佳 C 指数最高(0.97,p 值:0.0001)。CMR-TT 的应变分析可能具有很高的能力,既能识别早期心脏受累,又能分层其临床侵袭性,而与标准损害指数和 CMR 对比依赖生物标志物无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/413a/8948177/5535939740ef/41598_2022_9064_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/413a/8948177/989a5d16599b/41598_2022_9064_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/413a/8948177/5535939740ef/41598_2022_9064_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/413a/8948177/989a5d16599b/41598_2022_9064_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/413a/8948177/5535939740ef/41598_2022_9064_Fig2_HTML.jpg

相似文献

1
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis.心脏磁共振平扫可能提高隐匿性系统性硬化症无症状患者心脏受累的检出率和预测预后。
Sci Rep. 2022 Mar 24;12(1):5125. doi: 10.1038/s41598-022-09064-5.
2
Cardiac Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study.心脏体素内不相干运动弥散加权磁共振成像 T1 mapping 评估系统性硬化症患者的心肌灌注和纤维化:来自前瞻性队列研究的与心脏事件的相关性。
Arthritis Rheumatol. 2020 Sep;72(9):1571-1580. doi: 10.1002/art.41308. Epub 2020 Aug 2.
3
T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.心脏磁共振 T1 mapping 成像技术常可检测出系统性硬化症患者亚临床弥漫性心肌纤维化。
Semin Arthritis Rheum. 2020 Feb;50(1):128-134. doi: 10.1016/j.semarthrit.2019.06.013. Epub 2019 Jun 19.
4
Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.系统性硬化症患者心肌炎症的临床及实验室指标预测:一项心脏磁共振成像检测的初步研究
Int J Rheum Dis. 2019 Dec;22(12):2125-2133. doi: 10.1111/1756-185X.13727. Epub 2019 Oct 29.
5
Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.磁共振成像检测到的心肌纤维化、升高的 U-CRP 和更高的 mRSS 是系统性硬化症 (SSc) 患者心血管并发症的预测因子。
Semin Arthritis Rheum. 2019 Oct;49(2):273-278. doi: 10.1016/j.semarthrit.2019.02.005. Epub 2019 Feb 11.
6
Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.心脏受累于系统性硬化症:磁共振成像的作用
Clin Rev Allergy Immunol. 2023 Jun;64(3):343-357. doi: 10.1007/s12016-022-08923-3. Epub 2022 Jan 24.
7
Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients - Relationship with biochemical and echocardiography parameters.磁共振检测系统性硬化症患者心肌纤维化 - 与生化和超声心动图参数的关系。
Int J Cardiol. 2017 Dec 15;249:448-453. doi: 10.1016/j.ijcard.2017.08.072. Epub 2017 Sep 18.
8
Late Gadolinium Enhancement in Cardiac Magnetic Resonance Imaging Is Associated with High Renal Resistive Index in Patients with Systemic Sclerosis.心脏磁共振成像延迟钆增强与系统性硬化症患者的高肾阻力指数相关。
Kidney Blood Press Res. 2020;45(2):350-356. doi: 10.1159/000505659. Epub 2020 Feb 26.
9
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset.药物负荷、静息灌注及延迟强化心脏磁共振成像可识别近期发病的系统性硬化症患者极早期的心脏受累情况。
Int J Rheum Dis. 2017 Sep;20(9):1247-1260. doi: 10.1111/1756-185X.13107. Epub 2017 Jun 4.
10
Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.系统性硬化症无症状患者右心室心肌功能与皮肤及肺部受累的相关性
Ital Heart J. 2004 Nov;5(11):831-9.

引用本文的文献

1
Emerging Imaging Techniques for Atherosclerosis in Systemic Immune-Mediated Inflammatory Conditions.系统性免疫介导炎症性疾病中动脉粥样硬化的新兴成像技术
Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):11-22. doi: 10.1161/ATVBAHA.124.321202. Epub 2024 Nov 14.
2
Heart involvement in patients with systemic sclerosis-what have we learned about it in the last 5 years.系统性硬化症患者的心脏受累——在过去的 5 年里,我们对此了解多少。
Rheumatol Int. 2024 Oct;44(10):1823-1836. doi: 10.1007/s00296-024-05699-x. Epub 2024 Aug 27.
3
Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging.

本文引用的文献

1
Real-world clinical validity of cardiac magnetic resonance tissue tracking in primitive hypertrophic cardiomyopathy.心脏磁共振组织追踪在原发性肥厚型心肌病中的真实世界临床有效性。
Radiol Med. 2021 Dec;126(12):1532-1543. doi: 10.1007/s11547-021-01432-x. Epub 2021 Dec 11.
2
Appropriate use criteria for cardiovascular magnetic resonance imaging (CMR): SIC-SIRM position paper part 1 (ischemic and congenital heart diseases, cardio-oncology, cardiac masses and heart transplant).心血管磁共振成像(CMR)的合理应用标准:SIC-SIRM 立场文件第 1 部分(缺血性和先天性心脏病、心脏肿瘤学、心脏肿块和心脏移植)。
Radiol Med. 2021 Mar;126(3):365-379. doi: 10.1007/s11547-020-01332-6. Epub 2021 Feb 24.
3
心力衰竭与心肌病:从基础到高级影像的CT与MR
Diagnostics (Basel). 2022 Sep 23;12(10):2298. doi: 10.3390/diagnostics12102298.
4
The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.硬皮病中平滑肌、横纹肌和心肌的参与:综述。
Int J Mol Sci. 2022 Oct 9;23(19):12011. doi: 10.3390/ijms231912011.
Myocarditis: imaging up to date.
心肌炎:最新影像学进展。
Radiol Med. 2020 Nov;125(11):1124-1134. doi: 10.1007/s11547-020-01279-8. Epub 2020 Oct 6.
4
Cardiac magnetic resonance in arrhythmogenic cardiomyopathies.心律失常性心肌病的心脏磁共振成像。
Radiol Med. 2020 Nov;125(11):1087-1101. doi: 10.1007/s11547-020-01289-6. Epub 2020 Sep 25.
5
Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies.限制性心肌病的心血管磁共振(CMR)。
Radiol Med. 2020 Nov;125(11):1072-1086. doi: 10.1007/s11547-020-01287-8. Epub 2020 Sep 24.
6
Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies.肥厚型和扩张型心肌病的心脏磁共振成像。
Radiol Med. 2020 Nov;125(11):1056-1071. doi: 10.1007/s11547-020-01276-x. Epub 2020 Sep 18.
7
Cardiac MRI: technical basis.心脏 MRI:技术基础。
Radiol Med. 2020 Nov;125(11):1040-1055. doi: 10.1007/s11547-020-01282-z. Epub 2020 Sep 16.
8
CMR in the diagnosis of ischemic heart disease.CMR 在缺血性心脏病诊断中的应用。
Radiol Med. 2020 Nov;125(11):1114-1123. doi: 10.1007/s11547-020-01278-9. Epub 2020 Sep 16.
9
The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making.达摩克利斯之剑高悬:系统性硬化症中的心脏受累及非侵入性成像方式在医疗决策中的作用。
Eur J Rheumatol. 2020 Oct;7(Suppl 3):S203-S211. doi: 10.5152/eurjrheum.2020.19110. Epub 2020 Jul 20.
10
Multimodality imaging in chronic heart failure.多模态影像学在慢性心力衰竭中的应用。
Radiol Med. 2021 Feb;126(2):231-242. doi: 10.1007/s11547-020-01245-4. Epub 2020 Jul 16.